ELECTROCHEMOTHERAPY IN THE TREATMENT OF UNRESECTABLE PANCREATIC CANCER
Pancreatic cancer (PC) is a malignant tumor with a poor prognosis and an extremely low 5-year survival rate. No more than 10% of patients have local cancer of the pancreas; in the rest, at the time of the initial diagnosis, it is already a systemic disease. In most patients, relapse occurs within th...
Saved in:
Main Author: | A. A. Kovalev |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2022-03-01
|
Series: | Сучасні медичні технології |
Subjects: | |
Online Access: | https://zmapo-journal.com/index.php/journal/article/view/178 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Electrochemotherapy with bleomycin, oxaliplatin, or cisplatin in mouse tumor models, from tumor ablation to in situ vaccination
by: Katja Uršič Valentinuzzi, et al.
Published: (2025-02-01) -
Electrochemotherapy in the Locoregional Treatment of Metastatic Colorectal Liver Metastases: A Systematic Review
by: Pierluigi Barbieri, et al.
Published: (2024-11-01) -
Complications of Percutaneous Irreversible Electroporation for Pancreatic Cancer: A Systematic Review
by: Harsimran Bhatia, et al. -
Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation
by: Chaobin He, et al.
Published: (2020-07-01) -
Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance
by: Nina Rembiałkowska, et al.
Published: (2022-03-01)